These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4700499)

  • 1. The antimycotic activity of 5-fluorocytosine.
    Holt RJ; Newman RL
    J Clin Pathol; 1973 Mar; 26(3):167-74. PubMed ID: 4700499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory assessment of the antimycotic drug clotrimazole.
    Holt RJ; Newman RL
    J Clin Pathol; 1972 Dec; 25(12):1089-97. PubMed ID: 4655860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-fluorocytosine in the treatment of cryptococcal and candida mycoses.
    Fass RJ; Perkins RL
    Ann Intern Med; 1971 Apr; 74(4):535-9. PubMed ID: 5551162
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro studies with 5-fluorocytosine.
    Shadomy S
    Appl Microbiol; 1969 Jun; 17(6):871-7. PubMed ID: 5797940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-fluorocytosine and urinary candidiasis.
    Davies RR; Reeves DS
    Br Med J; 1971 Mar; 1(5749):577-9. PubMed ID: 5548298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of urinary candidosis with the oral antifungal drugs 5-fluorocytosine and 'clotrimazole'.
    Holt RJ; Newman RL
    Dev Med Child Neurol Suppl; 1972; 27():70-9. PubMed ID: 4566706
    [No Abstract]   [Full Text] [Related]  

  • 7. 5-fluorocytosine: a replacement for amphotericin B in the treatment of candida and cryptococcus neoformans infections?
    Pankey GA; Lockwood WR; Montalvo JM
    J La State Med Soc; 1970 Dec; 122(12):365-9. PubMed ID: 5492591
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antimycotic activity in vitro and in vivo of 5-fluorocytosine on pathogenic strains of Candida albicans and Cryptococcus neoformans].
    Costa AL; Valenti A; Costa G; Calogero F
    G Batteriol Virol Immunol; 1976; 69(7-12):244-9. PubMed ID: 800772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental and clinical studies of 5-fluorocytosine activity in Candida ocular infections. I. In vitro activity of 5-fluorocytosine on Candida species isolated from ocular infections.
    Segal E; Romano A; Eylan E; Stein R
    Chemotherapy; 1975; 21(6):358-66. PubMed ID: 1183243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience.
    Steer PL; Marks MI; Klite PD; Eickhoff TC
    Ann Intern Med; 1972 Jan; 76(1):15-22. PubMed ID: 5063168
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata.
    Normark S; Schönebeck J
    Antimicrob Agents Chemother; 1972 Sep; 2(3):114-21. PubMed ID: 4597703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Fluorocytosine resistance in candida spp. and Torulopsis glabrata.
    Schönebeck J; Anséhn S
    Sabouraudia; 1973 Mar; 11(1):10-20. PubMed ID: 4574129
    [No Abstract]   [Full Text] [Related]  

  • 13. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-fluorocytosine resistance in Cryptococcus neoformans.
    Block ER; Jennings AE; Bennett JE
    Antimicrob Agents Chemother; 1973 Jun; 3(6):649-56. PubMed ID: 4597734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
    Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
    Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic activity of 5-fluorocytosine against a lethal Candida albicans infection in mice.
    Pittillo RF; Ray BJ
    Appl Microbiol; 1969 May; 17(5):773-4. PubMed ID: 5785966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two cases of cryptococcal meningitis, one treated with 5-fluorocytosine.
    Watkins JS; Campbell MJ; Gardner-Medwin D; Ingham HR; Murray IG
    Br Med J; 1969 Jul; 3(5661):29-31. PubMed ID: 5787281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further in vitro studies with 5-fluorocytosine.
    Shadomy S
    Infect Immun; 1970 Oct; 2(4):484-8. PubMed ID: 16557866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of 5-fluorocytosine on nucleic acid synthesis in Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus.
    Polak A; Wain WH
    Chemotherapy; 1977; 23(4):243-59. PubMed ID: 324722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.